Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 294

1.

Medication development and testing in children and adolescents. Current problems, future directions.

Vitiello B, Jensen PS.

Arch Gen Psychiatry. 1997 Sep;54(9):871-6. Review.

PMID:
9294379
2.

Psychopharmacology for young children: clinical needs and research opportunities.

Vitiello B.

Pediatrics. 2001 Oct;108(4):983-9. Review.

PMID:
11581454
3.

Developing methodologies for monitoring long-term safety of psychotropic medications in children: report on the NIMH conference, September 25, 2000.

Greenhill LL, Vitiello B, Abikoff H, Levine J, March JS, Riddle MA, Capasso L, Cooper TB, Davies M, Fisher P, Findling RL, Fried J, Labellarte MJ, McCracken JT, McMahon D, Robinson J, Skrobala A, Scahill L, Varipatis E, Walkup JT, Zito JM.

J Am Acad Child Adolesc Psychiatry. 2003 Jun;42(6):651-5.

PMID:
12921472
4.

Psychoactive medication prescribing practices for U.S. children: gaps between research and clinical practice.

Jensen PS, Bhatara VS, Vitiello B, Hoagwood K, Feil M, Burke LB.

J Am Acad Child Adolesc Psychiatry. 1999 May;38(5):557-65. Review.

PMID:
10230187
5.

Research in child and adolescent psychopharmacology: recent accomplishments and new challenges.

Vitiello B.

Psychopharmacology (Berl). 2007 Mar;191(1):5-13. Epub 2006 May 23. Review.

PMID:
16718480
6.

Child and adolescent psychopharmacology in the new millennium: a workshop for academia, industry, and government.

DeVeaugh-Geiss J, March J, Shapiro M, Andreason PJ, Emslie G, Ford LM, Greenhill L, Murphy D, Prentice E, Roberts R, Silva S, Swanson JM, van Zwieten-Boot B, Vitiello B, Wagner KD, Mangum B.

J Am Acad Child Adolesc Psychiatry. 2006 Mar;45(3):261-70.

PMID:
16540810
7.

Psychopharmacology for children: from off label use to registration.

Wohlfarth T, Kalverdijk L, Rademaker C, Schothorst P, Minderaa R, Gispen-de Wied C.

Eur Neuropsychopharmacol. 2009 Aug;19(8):603-8. doi: 10.1016/j.euroneuro.2009.04.007. Epub 2009 May 9. Review.

PMID:
19428221
8.

Procedures and methods of benefit assessments for medicines in Germany.

Bekkering GE, Kleijnen J.

Eur J Health Econ. 2008 Nov;9 Suppl 1:5-29. doi: 10.1007/s10198-008-0122-5.

PMID:
18987905
9.

AACAP 2002 research forum: placebo and alternatives to placebo in randomized controlled trials in pediatric psychopharmacology.

March J, Kratochvil C, Clarke G, Beardslee W, Derivan A, Emslie G, Green EP, Heiligenstein J, Hinshaw S, Hoagwood K, Jensen P, Lavori P, Leonard H, McNulty J, Michaels MA, Mossholder A, Osher T, Petti T, Prentice E, Vitiello B, Wells K.

J Am Acad Child Adolesc Psychiatry. 2004 Aug;43(8):1046-56.

PMID:
15266201
10.

Regulatory issues in pediatric psychopharmacology.

Laughren TP.

J Am Acad Child Adolesc Psychiatry. 1996 Oct;35(10):1276-82. Review.

PMID:
8885581
11.

Family pediatrics: report of the Task Force on the Family.

Schor EL; American Academy of Pediatrics Task Force on the Family..

Pediatrics. 2003 Jun;111(6 Pt 2):1541-71.

PMID:
12777595
12.

A survey of off-label prescribing for inpatients with mild intellectual disability and mental illness.

Haw C, Stubbs J.

J Intellect Disabil Res. 2005 Nov;49(Pt 11):858-64.

PMID:
16207284
13.

Ethical issues in psychopharmacology of children and adolescents.

Koelch M, Schnoor K, Fegert JM.

Curr Opin Psychiatry. 2008 Nov;21(6):598-605. doi: 10.1097/YCO.0b013e328314b776. Review.

PMID:
18852568
14.

The future of pediatric psychopharmacology.

Walkup JT, Cruz K, Kane S, Geller B.

Pediatr Clin North Am. 1998 Oct;45(5):1265-78. Review.

PMID:
9884685
15.

[Off-label use of psychotropic medications in pediatric wards: a prospective study].

Winterfeld U, Le Heuzey MF, Acquaviva E, Mouren MC, Brion F, Bourdon O.

Arch Pediatr. 2009 Sep;16(9):1252-60. doi: 10.1016/j.arcped.2009.06.012. Epub 2009 Jul 28. French.

PMID:
19640689
16.

Ethical challenges in neonatal research: Summary report of the ethics group of the newborn drug development initiative.

Baer GR, Nelson RM; Ethics Group of the Newborn Drug Development Initiative..

Clin Ther. 2006 Sep;28(9):1399-407. Review.

PMID:
17062312
17.

Developmental perspectives in pediatric psychopharmacology.

Vitiello B, Jensen PS.

Psychopharmacol Bull. 1995;31(1):75-81. Review.

PMID:
7675993
18.

Development and natural history of mood disorders.

Costello EJ, Pine DS, Hammen C, March JS, Plotsky PM, Weissman MM, Biederman J, Goldsmith HH, Kaufman J, Lewinsohn PM, Hellander M, Hoagwood K, Koretz DS, Nelson CA, Leckman JF.

Biol Psychiatry. 2002 Sep 15;52(6):529-42.

PMID:
12361667
19.

Newborns and drug studies: the NICHD/FDA newborn drug development initiative.

Giacoia GP, Mattison DR.

Clin Ther. 2005 Jun;27(6):796-813.

PMID:
16117987
20.

The economics of pediatric formulation development for off-patent drugs.

Milne CP, Bruss JB.

Clin Ther. 2008 Nov;30(11):2133-45. doi: 10.1016/j.clinthera.2008.11.019. Review.

PMID:
19108801

Supplemental Content

Support Center